Yum! Brands’ Board of Directors is Eating Up Stock

Yum! Brands board of directors: Strong insider activity has been going on at Yum! Brands, Inc. (NYSE:YUM). Yesterday, D Robert Walter, a Director on the Board, acquired 20,000 company shares at an average price of $66.0858 (the transaction was actually executed in multiple trades at prices ranging from $66.02 to $66.12). The transaction totaled more than $1,321,700, and leaves Mr. Walter’s holdings at 108,301 shares, valued at $7.2 million.

Yum! Brands, Inc. (NYSE:YUM)

In addition, two other insiders, Guiton Bonnie Hill, Director, and David Jonathan Blum, Senior Vice President and Chief of Public Affairs, purchased stock from the company last Thursday. However, their situations differ slightly from Walter’s. Hill acquired 3,546 shares at $16.9275, making use of some stock options that she holds. Additionally, she sold 2,270 shares at an average price of $65.933, making a big profit. Blum did something similar: he sold 9,500 shares at more than $66 each (actually, he sold them in two rounds, at $66.43 and $66.49), and bought the same amount, paying $29.29 per share, using Stock Appreciation Rights that he owns.

The purchases follow the third quarter earnings call, which took place on Oct. 9th. Even though results came in below analyst projections and the company is still struggling in China mainly due to bad publicity, an avian flu scare and the sluggish Chinese economy, these insiders seem to still deposit their trust on the firm.

Another fact that may have motivated the purchases is Yum’s recent announcement of a quarterly dividend, which is scheduled for Friday, November 1st. Investors of record on Friday, October 11th, will receive a dividend of $0.37 per share, more than 2% of the current stock price.

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Ferrellgas Insider Trading Activity Continues

Are CommunityOne Bancorp Directors Looking for a Rebound?

Bassett Furniture Insider Buying Heats Up

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!